drugset / Trial / NCT04205916

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

NCT04205916 ↗

RandomizedSingle-groupOpen-labelOther

Summary

To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.

Timeline

Start
2019-11-04
Primary completion
2020-06-30
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Other

Indications

No indication recorded.